28 results
424B5
PRME
Prime Medicine Inc
16 Feb 24
Prospectus supplement for primary offering
6:17am
the disposition, which may be offset by certain U.S. source capital losses of the non-U.S. holder, if any (even though the individual is not considered
424B5
PRME
Prime Medicine Inc
14 Feb 24
Prospectus supplement for primary offering
5:27pm
be offset by certain U.S. source capital losses of the non-U.S. holder, if any (even though the individual is not considered a resident of the United States
S-3
PRME
Prime Medicine Inc
3 Nov 23
Shelf registration
5:23pm
be offset by certain U.S. source capital losses of the non-U.S. holder, if any (even though the individual is not considered a resident of the United States
10-Q
8bnbcsxlslvfvo7
14 Nov 22
Quarterly report
4:46pm
424B4
yk3w xcsc9iw95bh6o
21 Oct 22
Prospectus supplement with pricing info
4:47pm
S-1/A
rsgblbunefg8
13 Oct 22
IPO registration (amended)
10:51am
S-1/A
EX-10.1
dvsnbzpzbga ojsu3
13 Oct 22
IPO registration (amended)
10:51am
S-1
EX-10.1
4qehhj2f ov69ns
23 Sep 22
IPO registration
4:12pm
S-1
EX-10.14
mv802hamurzk7y
23 Sep 22
IPO registration
4:12pm
S-1
kmf6c4u4i 4n
23 Sep 22
IPO registration
4:12pm
S-1
EX-10.13
c71xzb3 3z95se0novax
23 Sep 22
IPO registration
4:12pm
DRS/A
l12a2f
5 Aug 22
Draft registration statement (amended)
12:00am
DRS/A
qu5 9oiy2muyi
6 May 22
Draft registration statement (amended)
12:00am